Kelly Knee

Principal Scientist
Haematology
pfizer
Poland

Business Expert Haematology
Biography

Kelly Knee joined Pfizer in 2012. After receiving her Ph.D. in 2007 from Wesleyan University, she went on to do a postdoctoral research fellowship at the MIT, Cambridge from 2007-2011. Later, she worked as a Strategic Consultant in Global Blood Therapeutics from 2011-2012. Kelly Knee now working as a Principal Scientist Rare Disease Research Unit at Pfizer.

Research Intrest

Kelly Knee has broad interests on Haemophilic Diseases. Her major focus of research on sickle cell diseases.